The nation of Zimbabwe has declined a significant US health deal valued at $367m (£272m) spanning five years due to Washington's request for sensitive information.
This move came to light following a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the deal was "skewed".
A government representative later clarified that the US was seeking genetic material for research and commercial purposes while was unwilling to guarantee the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate process of winding down our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had provided more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged more dialogue to reach a deal suitable to both sides so the country's vital HIV treatment initiative can be sustained.
Wider Context
Zimbabwe's decision comes after a similar situation in Kenya, where a high court blocked a related deal with the US following legal challenges were raised about the safety of citizens' health data.
After returning to the presidency last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
USAID had administered assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government agreements to enhance transparency and accountability.
As per statements, 16 African countries have to date signed these new agreements, constituting more than $18.3bn in new funding.
Details of the Declined Deal
The funds for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration might have yielded extraordinary advantages for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy through American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Our nation was requested to share its genetic material and health information indefinitely, without any equivalent promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.
"Effectively, our country would supply the basic resources for scientific discovery with no assurance that the final treatments would be accessible to our people should a future health crisis arise."
Sovereignty and Global Health
Mangwana further said that the American exit from the global health body and its push of bilateral health agreements were undermining systems already set up via the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing framework created to deal with potential pandemics.
"This framework is intended to guarantee that when a country contributes its samples, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to continued dialogue with our American counterparts on how subsequent co-operation might be structured in a manner that respects the independence and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but urged that negotiations must proceed since a large portion of the country's HIV programmes were funded by foreign aid.
"Where technical issues exist, including those involving information security or implementation frameworks, these can often be addressed through technical clarification and mutually agreed protections," the group commented.
The halted deal emphasises the complex debate between accepting much-needed international aid and safeguarding local interests in an increasingly data-driven world.